ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $7,000 | 0.0% | 5,195 | +6.1% | 0.00% | – |
| Q4 2016 | $7,000 | -12.5% | 4,895 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +14.3% | 4,895 | +11.4% | 0.00% | – |
| Q2 2016 | $7,000 | -12.5% | 4,395 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | +14.3% | 4,395 | +12.8% | 0.00% | – |
| Q4 2015 | $7,000 | -12.5% | 3,895 | -9.3% | 0.00% | – |
| Q3 2015 | $8,000 | -60.0% | 4,295 | 0.0% | 0.00% | – |
| Q2 2015 | $20,000 | -13.0% | 4,295 | -17.3% | 0.00% | – |
| Q1 2015 | $23,000 | +27.8% | 5,195 | -1.9% | 0.00% | – |
| Q4 2014 | $18,000 | -25.0% | 5,295 | -8.7% | 0.00% | -100.0% |
| Q3 2014 | $24,000 | -40.0% | 5,800 | -14.7% | 0.00% | 0.0% |
| Q2 2014 | $40,000 | -7.0% | 6,800 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $43,000 | -70.9% | 6,800 | -73.1% | 0.00% | -80.0% |
| Q4 2013 | $148,000 | +57.4% | 25,300 | +42.5% | 0.01% | +66.7% |
| Q3 2013 | $94,000 | -35.2% | 17,750 | -5.8% | 0.00% | -40.0% |
| Q2 2013 | $145,000 | – | 18,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |